Show simple item record

dc.contributor.authorPanek, R
dc.contributor.authorSchmidt, MA
dc.contributor.authorBorri, M
dc.contributor.authorKoh, D-M
dc.contributor.authorRiddell, A
dc.contributor.authorWelsh, L
dc.contributor.authorDunlop, A
dc.contributor.authorPowell, C
dc.contributor.authorBhide, SA
dc.contributor.authorNutting, CM
dc.contributor.authorHarrington, KJ
dc.contributor.authorNewbold, KL
dc.contributor.authorLeach, MO
dc.date.accessioned2017-01-03T12:16:48Z
dc.date.issued2016-11-01
dc.identifier.citationMedical physics, 2016, 43 (11), pp. 6024 - ?
dc.identifier.issn0094-2405
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/355
dc.identifier.eissn2473-4209
dc.identifier.doi10.1118/1.4964795
dc.description.abstractPURPOSE: To investigate the effects of different time-resolved angiography with stochastic trajectories (TWIST) k-space undersampling schemes on calculated pharmacokinetic dynamic contrast-enhanced (DCE) vascular parameters. METHODS: A digital perfusion phantom was employed to simulate effects of TWIST on characteristics of signal changes in DCE. Furthermore, DCE-MRI was acquired without undersampling in a group of patients with head and neck squamous cell carcinoma and used to simulate a range of TWIST schemes. Errors were calculated as differences between reference and TWIST-simulated DCE parameters. Parametrical error maps were used to display the averaged results from all tumors. RESULTS: For a relatively wide range of undersampling schemes, errors in pharmacokinetic parameters due to TWIST were under 10% for the volume transfer constant, Ktrans, and total extracellular extravascular space volume, Ve. TWIST induced errors in the total blood plasma volume, Vp, were the largest observed, and these were inversely dependent on the area of the fully sampled k-space. The magnitudes of errors were not correlated with Ktrans, Vp and weakly correlated with Ve. CONCLUSIONS: The authors demonstrated methods to validate and optimize k-space view-sharing techniques for pharmacokinetic DCE studies using a range of clinically relevant spatial and temporal patient derived data. The authors found a range of undersampling patterns for which the TWIST sequence can be reliably used in pharmacokinetic DCE-MRI. The parameter maps created in the study can help to make a decision between temporal and spatial resolution demands and the quality of enhancement curve characterization.
dc.formatPrint
dc.format.extent6024 - ?
dc.languageeng
dc.language.isoeng
dc.publisherWILEY
dc.subjectHumans
dc.subjectHead and Neck Neoplasms
dc.subjectContrast Media
dc.subjectMagnetic Resonance Imaging
dc.subjectAngiography
dc.subjectStochastic Processes
dc.subjectPhantoms, Imaging
dc.subjectAlgorithms
dc.subjectAdult
dc.subjectMiddle Aged
dc.subjectFemale
dc.subjectMale
dc.titleTime-resolved angiography with stochastic trajectories for dynamic contrast-enhanced MRI in head and neck cancer: Are pharmacokinetic parameters affected?
dc.typeJournal Article
rioxxterms.versionofrecord10.1118/1.4964795
rioxxterms.licenseref.startdate2016-11
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfMedical physics
pubs.issue11
pubs.notesNo embargo
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Magnetic Resonance
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Magnetic Resonance
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume43
pubs.embargo.termsNo embargo
icr.researchteamMagnetic Resonance
icr.researchteamTargeted Therapy
dc.contributor.icrauthorHarrington, Kevin
dc.contributor.icrauthorLeach, Martin


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record